These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30362886)

  • 1. Oxidized-LDL is a useful marker for predicting the very early coronary artery disease and cardiovascular outcomes.
    Zhao X; Zhang HW; Xu RX; Guo YL; Zhu CG; Wu NQ; Gao Y; Li JJ
    Per Med; 2018 Nov; 15(6):521-529. PubMed ID: 30362886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oxidation ratio of LDL: a predictor for coronary artery disease.
    Huang H; Mai W; Liu D; Hao Y; Tao J; Dong Y
    Dis Markers; 2008; 24(6):341-9. PubMed ID: 18688083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma oxidized low-density lipoprotein is an independent risk factor in young patients with coronary artery disease.
    Huang Y; Hu Y; Mai W; Cai X; Song Y; Wu Y; Dong Y; Huang H; He Z; Li W; Yang Y; Rao S
    Dis Markers; 2011; 31(5):295-301. PubMed ID: 22048271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of oxidized lipoprotein (a) in patients with acute coronary syndromes and stable coronary artery disease by 2 ELISAs: using different capture antibody against oxidized lipoprotein (a) or oxidized LDL.
    Wang JJ; Han AZ; Meng Y; Gong JB; Zhang CN; Li K; Liu YX
    Clin Biochem; 2010 Apr; 43(6):571-5. PubMed ID: 20060390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-density lipoprotein-associated variables and the severity of coronary artery disease: an untreated Chinese cohort study.
    Zhao X; Sun D; Xu RX; Guo YL; Zhu CG; Wu NQ; Zhang Y; Li S; Gao Y; Liu G; Dong Q; Li JJ
    Biomarkers; 2018 Nov; 23(7):647-653. PubMed ID: 29730953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Serum Levels of Inflammation, Fibrinolysis and Oxidative Stress Markers in Coronary Artery Disease Prediction: A Cross-Sectional Study.
    Abolhasani S; Shahbazloo SV; Saadati HM; Mahmoodi N; Khanbabaei N
    Arq Bras Cardiol; 2019; 113(4):667-674. PubMed ID: 31482948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of oxidized-low-density lipoprotein and high-density lipoprotein subfractions in non-treated patients with coronary artery disease.
    Zhao X; Zhang HW; Sun D; Xu RX; Guo YL; Sun J; Zhu CG; Wu NQ; Zhang Y; Li S; Li JJ
    Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106345. PubMed ID: 31278984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between level of circulating modified LDL and the extent of coronary artery disease in type 2 diabetic patients.
    El-Bassiouni EA; Helmy MH; El-Zoghby SM; El-Nabi Kamel MA; Hosny RM
    Br J Biomed Sci; 2007; 64(3):109-16. PubMed ID: 17910279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of oxidized-low-density lipoproteins are higher in patients with unstable angina and correlated with angiographic coronary complex plaques.
    Anselmi M; Garbin U; Agostoni P; Fusaro M; Pasini AF; Nava C; Keta D; Turri M; Zardini P; Vassanelli C; Lo Cascio V; Cominacini L
    Atherosclerosis; 2006 Mar; 185(1):114-20. PubMed ID: 15998517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidized low-density lipoprotein cholesterol and the ratio in the diagnosis and evaluation of therapeutic effect in patients with coronary artery disease.
    Huang H; Ma R; Liu D; Liu C; Ma Y; Mai W; Dong Y
    Dis Markers; 2012; 33(6):295-302. PubMed ID: 23089925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease.
    Holvoet P; Mertens A; Verhamme P; Bogaerts K; Beyens G; Verhaeghe R; Collen D; Muls E; Van de Werf F
    Arterioscler Thromb Vasc Biol; 2001 May; 21(5):844-8. PubMed ID: 11348884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease.
    Inoue T; Uchida T; Kamishirado H; Takayanagi K; Hayashi T; Morooka S
    J Am Coll Cardiol; 2001 Mar; 37(3):775-9. PubMed ID: 11693751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidized low-density lipoprotein and C-reactive protein have combined utility for better predicting prognosis after acute coronary syndrome.
    Zhang YC; Tang Y; Chen Y; Huang XH; Zhang M; Chen J; Sun YG; Li YG
    Cell Biochem Biophys; 2014 Mar; 68(2):379-85. PubMed ID: 23943054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating miR-106a may Function as Potential Biomarkers in Patients with Coronary Artery Disease.
    Ding H; Hu CX; Xu JK
    Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association between plasma adiponectin and small, dense low density lipoprotein in patients with coronary artery disease].
    Chen G; Qin Q; Li Y; Ren B; Lu YR; Kou L; Yang N; Feng JP; Zhao BR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Sep; 40(9):752-6. PubMed ID: 23141087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of MDA-LDL (malondialdehyde-modified low-density lipoprotein) as a prognostic marker for coronary artery disease in patients with type 2 diabetes mellitus.
    Kotani K; Tashiro J; Yamazaki K; Nakamura Y; Miyazaki A; Bujo H; Saito Y; Kanno T; Maekawa M
    Clin Chim Acta; 2015 Oct; 450():145-50. PubMed ID: 26265234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody against oxidized low density lipoprotein may predict progression or regression of atherosclerotic coronary artery disease.
    Inoue T; Uchida T; Kamishirado H; Takayanagi K; Morooka S
    J Am Coll Cardiol; 2001 Jun; 37(7):1871-6. PubMed ID: 11401125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in plasma levels of oxidized low-density lipoproteins in patients with coronary spastic angina.
    Kugiyama K; Sugiyama S; Soejima H; Kawano H; Sakamoto T; Takazoe K; Ogawa H; Doi H; Yasue H
    Atherosclerosis; 2001 Feb; 154(2):463-7. PubMed ID: 11166780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sensitive chemiluminescence imaging immunoassay for simultaneous detection of serum oxidized lipoprotein(a) and low density lipoprotein.
    Yu R; Song J; Wu J; Niu D; Ma L; Zong C; Ju H; Wang J
    Clin Chem Lab Med; 2014 Jun; 52(6):869-77. PubMed ID: 24421216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated plasma myeloperoxidase levels in relation to circulating inflammatory markers in coronary artery disease.
    Samsamshariat SZ; Basati G; Movahedian A; Pourfarzam M; Sarrafzadegan N
    Biomark Med; 2011 Jun; 5(3):377-85. PubMed ID: 21657847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.